相似文献
1
Induced pluripotent stem cell-derived vascular smooth muscle cells: methods and application.
Biochem J. 2015 Jan 15;465(2):185-94. doi: 10.1042/BJ20141078.
2
Differentiation and Application of Induced Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells.
Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):2026-2037. doi: 10.1161/ATVBAHA.117.309196. Epub 2017 Aug 31.
3
Vascular Smooth Muscle Cell Derived from IPS Cell of Moyamoya Disease - Comparative Characterization with Endothelial Cell Transcriptome.
J Stroke Cerebrovasc Dis. 2020 Dec;29(12):105305. doi: 10.1016/j.jstrokecerebrovasdis.2020.105305. Epub 2020 Sep 23.
4
Vascular Smooth Muscle Cells From Hypertensive Patient-Derived Induced Pluripotent Stem Cells to Advance Hypertension Pharmacogenomics.
Stem Cells Transl Med. 2015 Dec;4(12):1380-90. doi: 10.5966/sctm.2015-0126. Epub 2015 Oct 22.
5
Generation of Vascular Smooth Muscle Cells From Induced Pluripotent Stem Cells: Methods, Applications, and Considerations.
Circ Res. 2021 Mar 5;128(5):670-686. doi: 10.1161/CIRCRESAHA.120.318049. Epub 2021 Mar 4.
6
Updated perspectives on vascular cell specification and pluripotent stem cell-derived vascular organoids for studying vasculopathies.
Cardiovasc Res. 2022 Jan 7;118(1):97-114. doi: 10.1093/cvr/cvaa313.
7
Generation and Encapsulation of Human iPSC-Derived Vascular Smooth Muscle Cells for Proangiogenic Therapy.
Methods Mol Biol. 2022;2549:259-269. doi: 10.1007/7651_2021_378.
8
Induced pluripotent stem cells for regenerative cardiovascular therapies and biomedical discovery.
Adv Drug Deliv Rev. 2011 Apr 30;63(4-5):324-30. doi: 10.1016/j.addr.2011.01.013. Epub 2011 Mar 1.
9
Induction of vascular progenitor cells from endothelial cells stimulates coronary collateral growth.
Circ Res. 2012 Jan 20;110(2):241-52. doi: 10.1161/CIRCRESAHA.111.250126. Epub 2011 Nov 17.
10
Vascular smooth muscle cell differentiation from human stem/progenitor cells.
Methods. 2016 May 15;101:85-92. doi: 10.1016/j.ymeth.2015.12.004. Epub 2015 Dec 8.
引用本文的文献
1
Mesenchymal stem cells in craniofacial reconstruction: a comprehensive review.
Front Mol Biosci. 2024 Apr 16;11:1362338. doi: 10.3389/fmolb.2024.1362338. eCollection 2024.
2
3D printed biomimetic flexible blood vessels with iPS cell-laden hierarchical multilayers.
Biomed Eng Adv. 2022 Dec;4. doi: 10.1016/j.bea.2022.100065. Epub 2022 Nov 28.
3
Adult Mesenchymal Stem Cells and Derivatives in Improved Elastin Homeostasis in a Rat Model of Abdominal Aortic Aneurysms.
Stem Cells Transl Med. 2022 Aug 23;11(8):850-860. doi: 10.1093/stcltm/szac043.
4
Human Induced Pluripotent Stem Cell as a Disease Modeling and Drug Development Platform-A Cardiac Perspective.
Cells. 2021 Dec 9;10(12):3483. doi: 10.3390/cells10123483.
5
Methods for Differentiating hiPSCs into Vascular Smooth Muscle Cells.
Methods Mol Biol. 2022;2375:21-34. doi: 10.1007/978-1-0716-1708-3_3.
6
gain-of-function mutation modulates the stiffness of smooth muscle cells and compromises vascular mechanics.
iScience. 2021 Mar 2;24(4):102246. doi: 10.1016/j.isci.2021.102246. eCollection 2021 Apr 23.
7
Induced Pluripotent Stem Cells (iPSCs) in Vascular Research: from Two- to Three-Dimensional Organoids.
Stem Cell Rev Rep. 2021 Oct;17(5):1741-1753. doi: 10.1007/s12015-021-10149-3. Epub 2021 Mar 18.
8
Insights into Biomechanical and Proteomic Characteristics of Small Diameter Vascular Grafts Utilizing the Human Umbilical Artery.
Biomedicines. 2020 Aug 10;8(8):280. doi: 10.3390/biomedicines8080280.
9
A Dense Fibrillar Collagen Scaffold Differentially Modulates Secretory Function of iPSC-Derived Vascular Smooth Muscle Cells to Promote Wound Healing.
Cells. 2020 Apr 14;9(4):966. doi: 10.3390/cells9040966.
10
Patient and Disease-Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics.
Pharmacol Rev. 2020 Jan;72(1):320-342. doi: 10.1124/pr.116.013003.
本文引用的文献
1
Regenerative implants for cardiovascular tissue engineering.
Transl Res. 2014 Apr;163(4):321-41. doi: 10.1016/j.trsl.2014.01.014. Epub 2014 Jan 30.
2
Embryonic origins of human vascular smooth muscle cells: implications for in vitro modeling and clinical application.
Cell Mol Life Sci. 2014 Jun;71(12):2271-88. doi: 10.1007/s00018-013-1554-3. Epub 2014 Jan 18.
3
A systematic evaluation of integration free reprogramming methods for deriving clinically relevant patient specific induced pluripotent stem (iPS) cells.
PLoS One. 2013 Nov 26;8(11):e81622. doi: 10.1371/journal.pone.0081622. eCollection 2013.
4
Clinical therapy using iPSCs: hopes and challenges.
Genomics Proteomics Bioinformatics. 2013 Oct;11(5):294-8. doi: 10.1016/j.gpb.2013.09.002. Epub 2013 Sep 21.
5
Inhibition of pluripotent stem cell-derived teratoma formation by small molecules.
Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):E3281-90. doi: 10.1073/pnas.1303669110. Epub 2013 Aug 5.
6
Highly efficient induction and long-term maintenance of multipotent cardiovascular progenitors from human pluripotent stem cells under defined conditions.
Cell Res. 2013 Sep;23(9):1119-32. doi: 10.1038/cr.2013.102. Epub 2013 Jul 30.
7
Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds.
Science. 2013 Aug 9;341(6146):651-4. doi: 10.1126/science.1239278. Epub 2013 Jul 18.
8
Induction of pluripotency in mouse somatic cells with lineage specifiers.
Cell. 2013 May 23;153(5):963-75. doi: 10.1016/j.cell.2013.05.001.
9
Smooth muscle cells differentiated from reprogrammed embryonic lung fibroblasts through DKK3 signaling are potent for tissue engineering of vascular grafts.
Circ Res. 2013 May 24;112(11):1433-43. doi: 10.1161/CIRCRESAHA.111.300415. Epub 2013 Mar 25.
10
Steps toward safe cell therapy using induced pluripotent stem cells.
Circ Res. 2013 Feb 1;112(3):523-33. doi: 10.1161/CIRCRESAHA.111.256149.
Zotero 插件